Deiziane V. S. Costa
Danielle S. Macedo
Camila N. C. Lima- 1Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, VA, United States
- 2Department of Physiology and Pharmacology, Faculty of Medicine, Neuropsychopharmacology and Tranlational Psychiatry Laboratory, Drug Research and Development Center, Federal University of Ceara, Fortaleza, Brazil
Editorial on the Research Topic
Neuroinflammation and gut-brain axis: role of glia cells
Gut inflammation has been bidirectionally associated with neurological and psychiatric conditions in humans, supporting a potential role of the gut-brain axis (Heston et al., 2023; Bisgaard et al., 2023a,b; Rajkovaca Latic et al., 2024). Cognitive impairment, anxiety, and depressive-like behavioral phenotypes have also been reported to occur following recovery from gut inflammation in a preclinical mouse model (Zhang et al., 2022; Lee et al., 2024), allowing mechanistic studies and development of potential therapeutics. In dementia patients, increased levels of microbe-derived molecules such as p-cresol, iso-butyric acid and iso-valeric acid have been detected in fecal samples (Saji et al., 2020), which supports the contribution of gut-derived molecules to this neurological condition.
Dementia is a general term for loss of memory and other thinking abilities severe enough to interfere with daily life. Stroke, Alzheimer's disease (AD) and Parkinson's disease (PD) are common causes of dementia (Livingston et al., 2024). The four papers collected for our special issues, which included three reviews and one original article, discussed about how gut microbiota and/or enteric glia contributes to acute ischemic stroke (AIS), AD, and PD (Figure 1).
Figure 1. Impact of the gut-brain axis on neurodegenerative diseases. Overview of the included studies on the Research Topic Gut-Brain Axis: Role of Glial Cells.
Deng et al. performed an epidemiologic study of 499 acute ischemic stroke (AIS) patients in combination with preclinical model studies in the Bama miniature (BM) pig model to investigate the contribution of gut microbiota-derived metabolites in AIS. A phenomenon of delayed bowel movements was observed in large hemispheric infarction (LHI) patients, which may be induced by a strike to the gut-brain axis. 1H NMR-based metabolomics was also employed to reveal a global metabolic profile in the plasma of AIS patients. Subsequently, a Bama miniature (BM) pig model with LHI was successfully established and employed to investigate alterations in intestinal barrier integrity, the gut microbial community, and microbiota-derived metabolites. These findings highlight the contribution of the microbiome-gut-brain axis in both clinical AIS patients and LHI BM pigs.
Alves et al. and Yan et al. provided an up-to-date review with a focus on AD. Alves et al. highlighted the potential of Drosophila as a robust model to investigate the association between the fly gut microbiota and the human microbiota, a connection that helps uncover the mechanisms linking bacterial balance to AD progression and inform future therapeutics. Yan et al. reviewed recent evidence on the role of acupuncture to modulate the gut microbiota as a therapy for AD and found that the evidence suggests that acupuncture combined with modulation of the gut microbiota may be beneficial in the treatment of AD in the future.
Finally, Thomasi et al. performed an elegant review on the potential role of enteric glia in PD. The authors focused on generating potential hypotheses on how enteric glial dysfunction may be connected to the development and/or progression of PD. Based on clinical data and animal models of PD in combination with other models of gut inflammation, the researchers explained how enteric glia and microbial molecules can affect each other, and how this interaction can impact gut dynamics, and the role of enteric glia in enteric neurotransmission, dysmotility, and visceral hypersensitivity. All of these aspects, at different stages of the disease, may be related to PD.
All these studies have provided insights into potential mechanisms related to gut-derived molecules, specifically microbiota and/or enteric glia, that could be targeted to prevent the progression of brain neuroinflammation associated with AD, PD and stroke.
Author contributions
DC: Conceptualization, Writing – original draft, Writing – review & editing. DM: Writing – original draft, Writing – review & editing. CL: Conceptualization, Writing – original draft, Writing – review & editing.
Acknowledgments
Figure 1 was created using Biorender.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
Bisgaard, T. H., Allin, K. H., Elmahdi, R., and Jess, T. (2023a). The bidirectional risk of inflammatory bowel disease and anxiety or depression: a systematic review and meta-analysis. Gen. Hosp. Psychiatry 83, 109–116. doi: 10.1016/j.genhosppsych.2023.05.002
Bisgaard, T. H., Poulsen, G., Allin, K. H., Keefer, L., Ananthakrishnan, A. N., and Jess, T. (2023b). Longitudinal trajectories of anxiety, depression, and bipolar disorder in inflammatory bowel disease: a population-based cohort study. EClinicalMedicine 59:101986. doi: 10.1016/j.eclinm.2023.101986
Heston, M. B., Hanslik, K. L., Zarbock, K. R., Harding, S. J., Davenport-Sis, N. J., Kerby, R. L., et al. (2023). Gut inflammation associated with age and Alzheimer's disease pathology: a human cohort study. Sci. Rep. 13:18924. doi: 10.1038/s41598-023-45929-z
Lee, K. I., Kim, M. S., Yuk, H. J., Jo, Y., Kim, H. J., Kim, J., et al. (2024). Alleviating depressive-like behavior in DSS-induced colitis mice: exploring naringin and poncirin from Poncirus trifoliata extracts. Biomed. Pharmacother. 175:116770. doi: 10.1016/j.biopha.2024.116770
Livingston, G., Huntley, J., Liu, K. Y., Costafreda, S. G., Selbæk, G., Alladi, S., et al. (2024). Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet 404, 572–628. doi: 10.1016/S0140-6736(24)01296-0
Rajkovaca Latic, I., Popovic, Z., Mijatovic, K., Sahinovic, I., Pekic, V., Vucic, D., et al. (2024). Association of intestinal inflammation and permeability markers with clinical manifestations of Parkinson's disease. Parkinsonism Relat. Disord. 123:106948. doi: 10.1016/j.parkreldis.2024.106948
Saji, N., Murotani, K., Hisada, T., Kunihiro, T., Tsuduki, T., Sugimoto, T., et al. (2020). Relationship between dementia and gut microbiome-associated metabolites: a cross-sectional study in Japan. Sci. Rep. 10:8088. doi: 10.1038/s41598-020-65196-6
Keywords: gut-brain axis, microbiota, glia, dementia, neurodegeneration
Citation: Costa DVS, Macedo DS and Lima CNC (2025) Editorial: Neuroinflammation and gut-brain axis: role of glia cells. Front. Neurosci. 19:1618286. doi: 10.3389/fnins.2025.1618286
Received: 25 April 2025; Accepted: 05 May 2025;
Published: 06 June 2025.
Edited and reviewed by: Silvia Turroni, University of Bologna, Italy
Copyright © 2025 Costa, Macedo and Lima. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Deiziane V. S. Costa, ZHYydEB2aXJnaW5pYS5lZHU=; Camila N. C. Lima, Y2FtaWxhY2FydmFsaG9lbmZAeWFob28uY29tLmJy